Abstract
MicroRNAs (miRNAs) are a class of small, noncoding RNAs that have been emerging as novel regulators in esophageal adenocarcinoma. Their role has been established in various aspects of esophageal adenocarcinoma including carcinogenesis, progression, treatment, and prognosis. Therefore, miRNA detection, profiling, and quantification have become extremely important for scientists and clinicians. As miRNAs are small, their detection can be challenging. There have been various methods developed to detect and/or quantify miRNAs. This chapter aims to introduce the fundamentals and methods of the most commonly used approaches including miRNA microarrays and quantitative real-time polymerase chain reaction (RT-qPCR) to detect and quantify miRNAs in esophageal adenocarcinoma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ambros V (2004) The functions of animal microRNAs. Nature 431:350–355. https://doi.org/10.1038/nature02871
Mamoori A, Gopalan V, Smith RA, Lam AK (2016) Modulatory roles of microRNAs in the regulation of different signalling pathways in large bowel cancer stem cells. Biol Cell 108:51–64. https://doi.org/10.1111/boc.201500062
Salajegheh A, Vosgha H, Rahman MA, Amin M, Smith RA, Lam AK (2016) Interactive role of miR-126 on VEGF-A and progression of papillary and undifferentiated thyroid carcinoma. Hum Pathol 51:75–85. https://doi.org/10.1016/j.humpath.2015.12.018
Gopalan V, Islam F, Pillai S, Tang JC, Tong DK, Law S, Chan KW, Lam AK (2016) Overexpression of microRNA-1288 in esophageal squamous cell carcinoma. Exp Cell Res 348:146–154. https://doi.org/10.1016/j.yexcr.2016.09.010
Gopalan V, Smith RA, Lam AK (2015) Downregulation of microRNA-498 in colorectal cancers and its cellular effects. Exp Cell Res 330:423–428. https://doi.org/10.1016/j.yexcr.2014.08.006
Chruscik A, Lam AK (2015) Clinical pathological impacts of microRNAs in papillary thyroid carcinoma: a crucial review. Exp Mol Pathol 99:393–398. https://doi.org/10.1016/j.yexmp.2015.08.013
Salajegheh A, Vosgha H, Md Rahman A, Amin M, Smith RA, Lam AK (2015) Modulatory role of miR-205 in angiogenesis and progression of thyroid cancer. J Mol Endocrinol 55:183–196. https://doi.org/10.1530/jme-15-0182
Ebrahimi F, Gopalan V, Wahab R, Lu CT, Smith RA, Lam AK (2015) Deregulation of miR-126 expression in colorectal cancer pathogenesis and its clinical significance. Exp Cell Res 339:333–341. https://doi.org/10.1016/j.yexcr.2015.10.004
Gopalan V, Pillai S, Ebrahimi F, Salajegheh A, Lam TC, Le TK, Langsford N, Ho YH, Smith RA, Lam AK (2014) Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance. Mol Carcinog 53(Suppl 1):E36–E44. https://doi.org/10.1002/mc.21993
Ebrahimi F, Gopalan V, Smith RA, Lam AK (2014) miR-126 in human cancers: clinical roles and current perspectives. Exp Mol Pathol 96:98–107. https://doi.org/10.1016/j.yexmp.2013.12.004
Maroof H, Salajegheh A, Smith RA, Lam AK (2014) Role of microRNA-34 family in cancer with particular reference to cancer angiogenesis. Exp Mol Pathol 97:298–304. https://doi.org/10.1016/j.yexmp.2014.08.002
Maroof H, Salajegheh A, Smith RA, Lam AK (2014) MicroRNA-34 family, mechanisms of action in cancer: a review. Curr Cancer Drug Targets 14:737–751
Lam A (2015) Chapter 2: Cellular and molecular biology of esophageal cancer. In: Saba NF, El-Rayes, Bassel F (eds) Esophageal cancer: prevention, diagnosis and therapy. Springer, New York, pp 25–40
Amin M, Lam AK (2015) Current perspectives of mi-RNA in esophageal adenocarcinoma: roles in predicting carcinogenesis, progression and values in clinical management. Exp Mol Pathol 98:411–418. https://doi.org/10.1016/j.yexmp.2015.03.002
Bobryshev YV, Orekhov AN, Chistiakov DA (2015) MicroRNAs in esophageal adenocarcinoma: functional significance and potential for the development of new molecular disease markers. Curr Pharm Des 21:3402–3416
Chen C, Zhang Y, Zhang L, Weakley SM, Yao Q (2011) MicroRNA-196: critical roles and clinical applications in development and cancer. J Cell Mol Med 15:14–23. https://doi.org/10.1111/j.1582-4934.2010.01219.x
Matsuzaki J, Suzuki H, Tsugawa H, Watanabe M, Hossain S, Arai E, Saito Y, Sekine S, Akaike T, Kanai Y, Mukaisho K, Auwerx J, Hibi T (2013) Bile acids increase levels of microRNAs 221 and 222, leading to degradation of CDX2 during esophageal carcinogenesis. Gastroenterology 145:1300–1311. https://doi.org/10.1053/j.gastro.2013.08.008
Hemmatzadeh M, Mohammadi H, Karimi M, Musavishenas MH, Baradaran B (2016) Differential role of microRNAs in the pathogenesis and treatment of Esophageal cancer. Biomed Pharmacother 82:509–519. https://doi.org/10.1016/j.biopha.2016.05.009
Derouet MF, Liu G, Darling GE (2014) MiR-145 expression accelerates esophageal adenocarcinoma progression by enhancing cell invasion and anoikis resistance. PLoS One 9:e115589. https://doi.org/10.1371/journal.pone.0115589
Wang Y, Zhao Y, Herbst A, Kalinski T, Qin J, Wang X, Jiang Z, Benedix F, Franke S, Wartman T, Camaj P, Halangk W, Kolligs FT, Jauch KW, Nelson PJ, Bruns CJ (2016) miR-221 mediates chemoresistance of esophageal adenocarcinoma by direct targeting of DKK2 expression. Ann Surg 264:804–814. https://doi.org/10.1097/sla.0000000000001928
Lynam-Lennon N, Bibby BA, Mongan AM, Marignol L, Paxton CN, Geiersbach K, Bronner MP, O'Sullivan J, Reynolds J, Maher SG (2016) Low miR-187 expression promotes resistance to chemoradiation therapy in vitro and correlates with treatment failure in patients with esophageal adenocarcinoma. Mol Med 22. https://doi.org/10.2119/molmed.2016.00020
Sugimura K, Miyata H, Tanaka K, Hamano R, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Mori M, Doki Y (2012) Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. Clin Cancer Res 18:5144–5153. https://doi.org/10.1158/1078-0432.ccr-12-0701
Hong L, Han Y, Zhang H, Li M, Gong T, Sun L, Wu K, Zhao Q, Fan D (2010) The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma. Ann Surg 251:1056–1063. https://doi.org/10.1097/SLA.0b013e3181dd4ea9
Hong L, Han Y, Lu Q, Zhang H, Zhao Q, Wu K, Fan D (2012) Drug resistance-related microRNAs in esophageal cancer. Expert Opin Biol Ther 12:1487–1494. https://doi.org/10.1517/14712598.2012.711309
Fassan M, Baffa R, Kiss A, Zaninotto G, Rugge M (2013) MicroRNA dysregulation in esophageal neoplasia: the biological rationale for novel therapeutic options. Curr Pharm Des 19:1236–1241
Garzon R, Marcucci G, Croce CM (2010) Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 9:775–789. https://doi.org/10.1038/nrd3179
Matsui D, Zaidi AH, Martin SA, Omstead AN, Kosovec JE, Huleihel L, Saldin LT, DiCarlo C, Silverman JF, Hoppo T, Finley GG, Badylak SF, Kelly RJ, Jobe BA (2016) Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma. Oncotarget 7:81281–81291
Tang S, Wu WK, Li X, Wong SH, Wong N, Chan MT, Sung JJ, Yu J (2016) Stratification of digestive cancers with different pathological features and survival outcomes by MicroRNA expression. Sci Rep 6:24466. https://doi.org/10.1038/srep24466
Leshkowitz D, Horn-Saban S, Parmet Y, Feldmesser E (2013) Differences in microRNA detection levels are technology and sequence dependent. RNA 19:527–538. https://doi.org/10.1261/rna.036475.112
Valoczi A, Hornyik C, Varga N, Burgyan J, Kauppinen S, Havelda Z (2004) Sensitive and specific detection of microRNAs by northern blot analysis using LNA-modified oligonucleotide probes. Nucleic Acids Res 32:e175. https://doi.org/10.1093/nar/gnh171
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33:e179. https://doi.org/10.1093/nar/gni178
Li W, Ruan K (2009) MicroRNA detection by microarray. Anal Bioanal Chem 394:1117–1124. https://doi.org/10.1007/s00216-008-2570-2
Pritchard CC, Cheng HH, Tewari M (2012) MicroRNA profiling: approaches and considerations. Nat Rev Genet 13:358–369. https://doi.org/10.1038/nrg3198
Love C, Dave S (2013) MicroRNA expression profiling using microarrays. Methods Mol Biol 999:285–296. https://doi.org/10.1007/978-1-62703-357-2_21
Bustin SA, Benes V, Nolan T, Pfaffl MW (2005) Quantitative real-time RT-PCR—a perspective. J Mol Endocrinol 34:597–601
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Amin, M., Islam, F., Gopalan, V., Lam, A.K. (2018). Detection and Quantification of MicroRNAs in Esophageal Adenocarcinoma. In: Lam, A. (eds) Esophageal Adenocarcinoma. Methods in Molecular Biology, vol 1756. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7734-5_22
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7734-5_22
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7733-8
Online ISBN: 978-1-4939-7734-5
eBook Packages: Springer Protocols